name,category,termsATPase, Ca++ transporting, plasma membrane 4,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005830$IPR006408:ATPase, P-type, calcium-transporting, PMCA-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, plasma membrane 4,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway]
ATPase, Ca++ transporting, plasma membrane 4,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, plasma membrane 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000924$membrane protein, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, plasma membrane 4,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850039441$chain:Plasma membrane calcium-transporting ATPase 4, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850111170$region of interest:Calmodulin-binding subdomain A, 850111171$region of interest:Calmodulin-binding subdomain B, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
BCL2-associated agonist of cell death,BBID[10000006$103.Ca2-calmodulin_PK_cascade, 10000042$159.14-3-3_Apoptosis, 10000068$46.P13K_PTEN, 10000089$69.Survival_signaling_BH3-Bad, 10000105$83.Growth_factors_Survival_factors_Mitogens, 10000108$86.Apoptosis_Nematode&_Vert]
BCL2-associated agonist of cell death,BIOCARTA[30000004$h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis, 30000014$h_aktPathway:AKT Signaling Pathway, 30000030$h_badPathway:Regulation of BAD phosphorylation, 30000060$h_ceramidePathway:Ceramide Signaling Pathway, 30000062$h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage, 30000127$h_gleevecpathway:Inhibition of Cellular Proliferation by Gleevec, 30000148$h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation, 30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets., 30000255$h_rasPathway:Ras Signaling Pathway, 30000292$h_tffPathway:Trefoil Factors Initiate  Mucosal Healing]
BCL2-associated agonist of cell death,INTERPRO[450000611$IPR000712:Apoptosis regulator Bcl-2, BH, 450017140$IPR018868:Pro-apoptotic Bcl-2 protein, BAD]
BCL2-associated agonist of cell death,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038843$hsa04210:Apoptosis, 470038852$hsa04370:VEGF signaling pathway, 470038853$hsa04510:Focal adhesion, 470038877$hsa04722:Neurotrophin signaling pathway, 470038882$hsa04910:Insulin signaling pathway, 470038891$hsa05010:Alzheimer's disease, 470038893$hsa05014:Amyotrophic lateral sclerosis (ALS), 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038902$hsa05212:Pancreatic cancer, 470038903$hsa05213:Endometrial cancer, 470038905$hsa05215:Prostate cancer, 470038908$hsa05218:Melanoma, 470038910$hsa05220:Chronic myeloid leukemia, 470038911$hsa05221:Acute myeloid leukemia, 470038913$hsa05223:Non-small cell lung cancer]
BCL2-associated agonist of cell death,SMART[760000305$SM00337:BCL]
BCL2-associated agonist of cell death,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001162$phosphoprotein, 790001212$polymorphism]
BCL2-associated agonist of cell death,UP_SEQ_FEATURE[850007430$chain:Bcl2 antagonist of cell death, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850117319$short sequence motif:BH3, 850118575$strand]
Cdc2-related kinase, arginine/serine-rich,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
Cdc2-related kinase, arginine/serine-rich,SMART[760000193$SM00220:S_TKc]
Cdc2-related kinase, arginine/serine-rich,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
Cdc2-related kinase, arginine/serine-rich,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010432$chain:Cell division protein kinase 12, 850102565$compositionally biased region:Poly-Ala, 850102580$compositionally biased region:Poly-Pro, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
F-box and leucine-rich repeat protein 13,COG_ONTOLOGY[90000112$Signal transduction mechanisms / RNA processing and modification]
F-box and leucine-rich repeat protein 13,INTERPRO[450001603$IPR001810:Cyclin-like F-box, 450005976$IPR006553:Leucine-rich repeat, cysteine-containing subtype]
F-box and leucine-rich repeat protein 13,PIR_SUPERFAMILY[630028327$PIRSF036848:conserved protein with F-box/LRR-repeat, Skp2 type]
F-box and leucine-rich repeat protein 13,SMART[760000228$SM00256:FBOX, 760000331$SM00367:LRR_CC]
F-box and leucine-rich repeat protein 13,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
F-box and leucine-rich repeat protein 13,UP_SEQ_FEATURE[850018787$chain:F-box/LRR-repeat protein 13, 850103725$domain:F-box, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
G protein-coupled receptor 107,INTERPRO[450008730$IPR009637:Transmembrane receptor, eukaryota]
G protein-coupled receptor 107,PIR_SUPERFAMILY[630010160$PIRSF011955:Caenorhabditis elegans hypothetical protein C15H9.5]
G protein-coupled receptor 107,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
G protein-coupled receptor 107,UP_SEQ_FEATURE[850046310$chain:Protein GPR107, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118623$transmembrane region]
SWAP switching B-cell complex 70kDa subunit,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
SWAP switching B-cell complex 70kDa subunit,SMART[760000205$SM00233:PH]
SWAP switching B-cell complex 70kDa subunit,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
SWAP switching B-cell complex 70kDa subunit,UP_SEQ_FEATURE[850063139$chain:Switch-associated protein 70, 850102577$compositionally biased region:Poly-Lys, 850104979$domain:PH, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
TNFAIP3 interacting protein 1,PIR_SUPERFAMILY[630029928$PIRSF038355:Nef-associated factor 1]
TNFAIP3 interacting protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
TNFAIP3 interacting protein 1,UP_SEQ_FEATURE[850064558$chain:TNFAIP3-interacting protein 1, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850113099$region of interest:Interacts with Nef, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,BIOCARTA[30000283$h_tall1Pathway:TACI and BCMA stimulation of B cell immune responses.]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,INTERPRO[450005489$IPR006052:Tumor Necrosis Factor, 450008180$IPR008983:Tumour necrosis factor-like]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038874$hsa04672:Intestinal immune network for IgA production]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,PIR_SUPERFAMILY[630030266$PIRSF038812:tumor necrosis factor ligand superfamily member 13]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,SMART[760000180$SM00207:TNF]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000081$angiogenesis, 790000109$Apoptosis, 790000264$cell membrane, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000402$cytokine, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000763$immune response, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001409$Signal-anchor, 790001555$transmembrane]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,UP_SEQ_FEATURE[850067174$chain:Tumor necrosis factor ligand superfamily member 12, membrane form, 850067175$chain:Tumor necrosis factor ligand superfamily member 12, secreted form, 850067176$chain:Tumor necrosis factor ligand superfamily member 13, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850117969$site:Cleavage, 850118052$site:Cleavage; by furin, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
actin, gamma 2, smooth muscle, enteric,INTERPRO[450003522$IPR004000:Actin/actin-like, 450003523$IPR004001:Actin, conserved site]
actin, gamma 2, smooth muscle, enteric,KEGG_PATHWAY[470038845$hsa04270:Vascular smooth muscle contraction]
actin, gamma 2, smooth muscle, enteric,PIR_SUPERFAMILY[630002457$PIRSF002337:Actin]
actin, gamma 2, smooth muscle, enteric,SMART[760000240$SM00268:ACTIN]
actin, gamma 2, smooth muscle, enteric,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000950$methylated amino acid, 790000995$muscle, 790000997$muscle protein, 790001063$nucleotide-binding, 790001417$smooth muscle]
actin, gamma 2, smooth muscle, enteric,UP_SEQ_FEATURE[850003547$chain:Actin, gamma-enteric smooth muscle, 850106258$modified residue, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict]
biogenesis of lysosomal organelles complex-1, subunit 2,INTERPRO[450017509$IPR019269:Biogenesis of lysosome-related organelles complex-1, subunit 2]
biogenesis of lysosomal organelles complex-1, subunit 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
biogenesis of lysosomal organelles complex-1, subunit 2,UP_SEQ_FEATURE[850008108$chain:Biogenesis of lysosome-related organelles complex 1 subunit 2, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
calcium channel, voltage-dependent, L type, alpha 1F subunit,INTERPRO[450001840$IPR002077:Voltage-dependent calcium channel, alpha-1 subunit, 450004905$IPR005446:Voltage-dependent calcium channel, L-type, alpha-1 subunit, 450005268$IPR005821:Ion transport, 450013322$IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain]
calcium channel, voltage-dependent, L type, alpha 1F subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038844$hsa04260:Cardiac muscle contraction, 470038845$hsa04270:Vascular smooth muscle contraction, 470038883$hsa04912:GnRH signaling pathway, 470038891$hsa05010:Alzheimer's disease, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
calcium channel, voltage-dependent, L type, alpha 1F subunit,OMIM_DISEASE[520000189$Aland Island eye disease, 520001161$Cone-rod dystrophy, X-linked, 3, 520003657$Night blindness, congenital stationary, X-linked, type 2, 520003658$Night blindness, congenital stationary, X-linked, type 2A, 520003738$Ocular albinism, Forsius-Eriksson type]
calcium channel, voltage-dependent, L type, alpha 1F subunit,PIR_SUPERFAMILY[630005588$PIRSF005657:voltage-gated calcium channel]
calcium channel, voltage-dependent, L type, alpha 1F subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000357$Cone-rod dystrophy, 790000366$Congenital stationary night blindness, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001377$sensory transduction, 790001555$transmembrane, 790001558$transport, 790001622$vision, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, L type, alpha 1F subunit,UP_SEQ_FEATURE[850100534$chain:Voltage-dependent L-type calcium channel subunit alpha-1F, 850102572$compositionally biased region:Poly-Glu, 850102575$compositionally biased region:Poly-Ile, 850102576$compositionally biased region:Poly-Leu, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850111061$region of interest:Binding to the beta subunit, 850111436$region of interest:Dihydropyridine binding, 850114003$region of interest:Phenylalkylamine binding, 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117294$sequence conflict, 850117295$sequence variant, 850117960$site:Calcium ion selectivity and permeability, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chemokine (C-C motif) ligand 24,BBID[10000012$109.Chemokine_families]
chemokine (C-C motif) ligand 24,INTERPRO[450000719$IPR000827:Small chemokine, C-C group, conserved site, 450001604$IPR001811:Small chemokine, interleukin-8-like]
chemokine (C-C motif) ligand 24,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
chemokine (C-C motif) ligand 24,PIR_SUPERFAMILY[630002087$PIRSF001950:small inducible chemokine, C/CC types]
chemokine (C-C motif) ligand 24,SMART[760000172$SM00199:SCY]
chemokine (C-C motif) ligand 24,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000775$inflammatory response, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
chemokine (C-C motif) ligand 24,UP_SEQ_FEATURE[850008617$chain:C-C motif chemokine 24, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
chromosome 1 open reading frame 21,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
chromosome 1 open reading frame 21,UP_SEQ_FEATURE[850073638$chain:Uncharacterized protein C1orf21, 850106258$modified residue]
chromosome 17 open reading frame 98,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 17 open reading frame 98,UP_SEQ_FEATURE[850073416$chain:Uncharacterized protein C17orf98, 850117295$sequence variant]
coiled-coil domain containing 51,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
coiled-coil domain containing 51,UP_SEQ_FEATURE[850012022$chain:Coiled-coil domain-containing protein 51, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
discs, large (Drosophila) homolog-associated protein 3,INTERPRO[450004495$IPR005026:Guanylate-kinase-associated protein]
discs, large (Drosophila) homolog-associated protein 3,PIR_SUPERFAMILY[630014622$PIRSF017965:disks large-associated protein 1]
discs, large (Drosophila) homolog-associated protein 3,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001475$synapse]
discs, large (Drosophila) homolog-associated protein 3,UP_SEQ_FEATURE[850015435$chain:Disks large-associated protein 3, 850102574$compositionally biased region:Poly-His, 850106258$modified residue]
dynactin 2 (p50),INTERPRO[450006392$IPR006996:Dynamitin]
dynactin 2 (p50),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynactin 2 (p50),SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000475$dynein, 790000919$membrane, 790000960$microtubule, 790001162$phosphoprotein]
dynactin 2 (p50),UP_SEQ_FEATURE[850016477$chain:Dynactin subunit 2, 850106258$modified residue, 850117294$sequence conflict]
family with sequence similarity 35, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
family with sequence similarity 35, member A,UP_SEQ_FEATURE[850045973$chain:Protein FAM35A, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
gastrin,INTERPRO[450001462$IPR001651:Gastrin/cholecystokinin peptide hormone, 450011789$IPR013152:Gastrin/cholecystokinin, conserved site]
gastrin,PIR_SUPERFAMILY[630001987$PIRSF001848:gastrin]
gastrin,SMART[760000021$SM00029:GASTRIN]
gastrin,SP_PIR_KEYWORDS[790000059$amidated carboxyl end, 790000060$amidation, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000708$hormone, 790001162$phosphoprotein, 790001212$polymorphism, 790001289$pyroglutamic acid, 790001291$Pyrrolidone carboxylic acid, 790001363$Secreted, 790001405$signal, 790001461$sulfation, 790001463$sulfoprotein]
gastrin,UP_SEQ_FEATURE[850106258$modified residue, 850106259$mutagenesis site, 850106680$peptide:Big gastrin, 850107690$peptide:Gastrin, 850107691$peptide:Gastrin-14, 850107694$peptide:Gastrin-52, 850107695$peptide:Gastrin-6, 850107696$peptide:Gastrin-71, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850117814$signal peptide, 850117969$site:Cleavage]
geminin, DNA replication inhibitor,INTERPRO[450009069$IPR009984:Geminin]
geminin, DNA replication inhibitor,PIR_SUPERFAMILY[630030014$PIRSF038488:Geminin]
geminin, DNA replication inhibitor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000461$dna replication inhibitor, 790001162$phosphoprotein, 790001212$polymorphism]
geminin, DNA replication inhibitor,UP_SEQ_FEATURE[850020875$chain:Geminin, 850105852$helix, 850106258$modified residue, 850117295$sequence variant]
hematopoietically expressed homeobox,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
hematopoietically expressed homeobox,KEGG_PATHWAY[470038889$hsa04950:Maturity onset diabetes of the young]
hematopoietically expressed homeobox,OMIM_DISEASE[520000059$A genome-wide association study identifies novel risk loci for type 2 diabetes, 520000069$A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants, 520001994$Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, 520003247$Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes, 520004248$Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes]
hematopoietically expressed homeobox,SMART[760000341$SM00389:HOX]
hematopoietically expressed homeobox,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001642$wnt signaling pathway]
hematopoietically expressed homeobox,UP_SEQ_FEATURE[850023261$chain:Hematopoietically-expressed homeobox protein hhex, 850102586$compositionally biased region:Pro-rich, 850102927$DNA-binding region:Homeobox, 850105852$helix, 850117294$sequence conflict]
heme oxygenase (decycling) 2,INTERPRO[450001817$IPR002051:Haem oxygenase, 450014438$IPR016053:Haem oxygenase-like, 450014457$IPR016084:Haem oxygenase-like, multi-helical, 450016494$IPR018207:Haem oxygenase conserved site]
heme oxygenase (decycling) 2,KEGG_PATHWAY[470038802$hsa00860:Porphyrin and chlorophyll metabolism]
heme oxygenase (decycling) 2,PIR_SUPERFAMILY[630000402$PIRSF000343:Haem_Oase, 630000403$PIRSF000343:heme oxygenase (decyclizing)]
heme oxygenase (decycling) 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000937$metal-binding, 790000959$microsome, 790001092$oxidoreductase, 790001212$polymorphism, 790001304$repeat]
heme oxygenase (decycling) 2,UP_SEQ_FEATURE[850023270$chain:Heme oxygenase 2, 850105852$helix, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106258$modified residue, 850116198$repeat:HRM 1, 850116199$repeat:HRM 2, 850117294$sequence conflict, 850117295$sequence variant, 850118624$turn]
hepatitis B virus x interacting protein,BIOCARTA[30000133$h_HBxPathway:Calcium Signaling by HBx of Hepatitis B virus]
hepatitis B virus x interacting protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001162$phosphoprotein]
hepatitis B virus x interacting protein,UP_SEQ_FEATURE[850023487$chain:Hepatitis B virus X-interacting protein, 850106258$modified residue, 850106259$mutagenesis site]
kallikrein-related peptidase 8,INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
kallikrein-related peptidase 8,SMART[760000013$SM00020:Tryp_SPc]
kallikrein-related peptidase 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001363$Secreted, 790001383$Serine protease, 790001405$signal, 790001652$zymogen]
kallikrein-related peptidase 8,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850027042$chain:Kallikrein-8, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
myotubularin related protein 14,INTERPRO[450014489$IPR016130:Protein-tyrosine phosphatase, active site]
myotubularin related protein 14,OMIM_DISEASE[520000892$Centronuclear myopathy, autosomal, modifier of]
myotubularin related protein 14,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000616$glycoprotein, 790000743$hydrolase, 790001162$phosphoprotein]
myotubularin related protein 14,UP_SEQ_FEATURE[850033104$chain:Myotubularin-related protein 14, 850102581$compositionally biased region:Poly-Ser, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
patatin-like phospholipase domain containing 2,INTERPRO[450002343$IPR002641:Patatin]
patatin-like phospholipase domain containing 2,OMIM_DISEASE[520003621$Neutral lipid storage disease with myopathy]
patatin-like phospholipase domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000743$hydrolase, 790000869$lipid degradation, 790000871$lipid droplet, 790000873$lipid metabolism, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
patatin-like phospholipase domain containing 2,UP_SEQ_FEATURE[850036892$chain:Patatin-like phospholipase domain- containing protein 2, 850104907$domain:Patatin, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117474$short sequence motif:GXSXG, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
phosphatidylinositol binding clathrin assembly protein,BIOCARTA[30000197$h_ndkDynaminPathway:Endocytotic role of NDK, Phosphins and Dynamin]
phosphatidylinositol binding clathrin assembly protein,INTERPRO[450008166$IPR008942:ENTH/VHS, 450010284$IPR011417:ANTH, 450012415$IPR013809:Epsin-like, N-terminal, 450013165$IPR014712:Clathrin adaptor, phosphoinositide-binding, GAT-like]
phosphatidylinositol binding clathrin assembly protein,OMIM_DISEASE[520002837$Leukemia, acute myeloid, 520002853$Leukemia, acute T-cell lymphoblastic]
phosphatidylinositol binding clathrin assembly protein,SMART[760000245$SM00273:ENTH]
phosphatidylinositol binding clathrin assembly protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000334$coated pit, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000496$Endocytosis, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001271$Proto-oncogene]
phosphatidylinositol binding clathrin assembly protein,UP_SEQ_FEATURE[850038475$chain:Phosphatidylinositol-binding clathrin assembly protein, 850103717$domain:ENTH, 850117294$sequence conflict, 850117295$sequence variant, 850117868$site:Breakpoint for translocation to form CALM/MLLT10 fusion protein, 850118574$splice variant]
phospholipase A2, group VI (cytosolic, calcium-independent),INTERPRO[450001870$IPR002110:Ankyrin, 450002343$IPR002641:Patatin]
phospholipase A2, group VI (cytosolic, calcium-independent),KEGG_PATHWAY[470038778$hsa00564:Glycerophospholipid metabolism, 470038779$hsa00565:Ether lipid metabolism, 470038780$hsa00590:Arachidonic acid metabolism, 470038781$hsa00591:Linoleic acid metabolism, 470038782$hsa00592:alpha-Linolenic acid metabolism, 470038827$hsa04010:MAPK signaling pathway, 470038845$hsa04270:Vascular smooth muscle contraction, 470038852$hsa04370:VEGF signaling pathway, 470038871$hsa04664:Fc epsilon RI signaling pathway, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038878$hsa04730:Long-term depression, 470038883$hsa04912:GnRH signaling pathway]
phospholipase A2, group VI (cytosolic, calcium-independent),OMIM_DISEASE[520002629$Infantile neuroaxonal dystrophy 1, 520002717$Karak syndrome, 520003591$Neurodegeneration with brain iron accumulation]
phospholipase A2, group VI (cytosolic, calcium-independent),SMART[760000220$SM00248:ANK]
phospholipase A2, group VI (cytosolic, calcium-independent),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000477$dystonia, 790000743$hydrolase, 790000869$lipid degradation, 790000919$membrane, 790001015$neurodegeneration, 790001108$Parkinsonism, 790001137$pharmaceutical, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
phospholipase A2, group VI (cytosolic, calcium-independent),UP_SEQ_FEATURE[850002914$chain:85 kDa calcium-independent phospholipase A2, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
potassium channel, subfamily K, member 7,INTERPRO[450002860$IPR003280:Potassium channel, two pore-domain, 450004866$IPR005408:Potassium channel, two pore-domain, TWIK, 450011743$IPR013099:Ion transport 2]
potassium channel, subfamily K, member 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
potassium channel, subfamily K, member 7,UP_SEQ_FEATURE[850040058$chain:Potassium channel subfamily K member 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850114080$region of interest:Pore-forming 1, 850114082$region of interest:Pore-forming 2, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
similar to defensin, beta 131; defensin, beta 131,SP_PIR_KEYWORDS[790000092$antibiotic, 790000100$Antimicrobial, 790000356$complete proteome, 790000418$defensin, 790000447$disulfide bond, 790001363$Secreted, 790001405$signal]
similar to defensin, beta 131; defensin, beta 131,UP_SEQ_FEATURE[850102883$disulfide bond, 850106652$peptide:Beta-defensin 131, 850117294$sequence conflict, 850117814$signal peptide]
small nucleolar RNA host gene 12 (non-protein coding),SP_PIR_KEYWORDS[790000356$complete proteome]
small nucleolar RNA host gene 12 (non-protein coding),UP_SEQ_FEATURE[850055521$chain:Putative uncharacterized protein SNHG12]
splA/ryanodine receptor domain and SOCS box containing 2,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450016640$IPR018355:SPla/RYanodine receptor subgroup]
splA/ryanodine receptor domain and SOCS box containing 2,SMART[760000225$SM00253:SOCS, 760000394$SM00449:SPRY]
splA/ryanodine receptor domain and SOCS box containing 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001593$ubl conjugation pathway]
splA/ryanodine receptor domain and SOCS box containing 2,UP_SEQ_FEATURE[850062256$chain:SPRY domain-containing SOCS box protein 2, 850103078$domain:B30.2/SPRY, 850105375$domain:SOCS box, 850105852$helix, 850118575$strand, 850118624$turn]
synapsin III,INTERPRO[450001203$IPR001359:Synapsin, 450012420$IPR013816:ATP-grasp fold, subdomain 2, 450017806$IPR019569:Synapsin N-terminal, 450017973$IPR019735:Synapsin, conserved site, 450017974$IPR019736:Synapsin, phosphorylation site]
synapsin III,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000211$calcium, 790000263$cell junction, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001475$synapse]
synapsin III,UP_SEQ_FEATURE[850063155$chain:Synapsin-3, 850105852$helix, 850106258$modified residue, 850110788$region of interest:A, 850110987$region of interest:B; linker, 850111152$region of interest:C; actin-binding and synaptic-vesicle binding, 850111549$region of interest:E, 850113231$region of interest:J; Pro-rich linker, 850118575$strand, 850118624$turn]
ubiquitination factor E4B (UFD2 homolog, yeast),INTERPRO[450003173$IPR003613:U box domain, 450017712$IPR019474:Ubiquitin conjugation factor E4, core]
ubiquitination factor E4B (UFD2 homolog, yeast),KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
ubiquitination factor E4B (UFD2 homolog, yeast),PIR_SUPERFAMILY[630013872$PIRSF017105:ubiquitin conjugation factor E4 with U-box domain, Ufd2 type]
ubiquitination factor E4B (UFD2 homolog, yeast),SMART[760000447$SM00504:Ubox]
ubiquitination factor E4B (UFD2 homolog, yeast),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001593$ubl conjugation pathway]
ubiquitination factor E4B (UFD2 homolog, yeast),UP_SEQ_FEATURE[850068026$chain:Ubiquitin conjugation factor E4 B, 850105596$domain:U-box, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118021$site:Cleavage; by caspase-3 and caspase-7, 850118028$site:Cleavage; by caspase-6 and granzyme B, 850118574$splice variant]
zinc finger, AN1-type domain 2B,INTERPRO[450000048$IPR000058:Zinc finger, AN1-type, 450003428$IPR003903:Ubiquitin interacting motif]
zinc finger, AN1-type domain 2B,SMART[760000136$SM00154:ZnF_AN1, 760000632$SM00726:UIM]
zinc finger, AN1-type domain 2B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
zinc finger, AN1-type domain 2B,UP_SEQ_FEATURE[850005193$chain:AN1-type zinc finger protein 2B, 850105852$helix, 850117162$repeat:UIM 1, 850117163$repeat:UIM 2, 850118574$splice variant, 850118575$strand, 850118635$zinc finger region:AN1-type 1, 850118636$zinc finger region:AN1-type 2]
